Objective Buprenorphine and fentanyl transdermal patches are used widely for the
management of persistent malignant and nonmalignant pain. Buprenorphine and fentanyl …

Objective: To evaluate the use of a buprenorphine transdermal patch (Transtec) in routine
clinical practice, including dosage, indications, efficacy and tolerability. Research design …

Advanced patch technology has yielded a novel transdermal therapeutic system (TDS) for
the rate-controlled systemic delivery of buprenorphine. Buprenorphine TDS is available in …

BACKGROUND:: Transdermal buprenorphine is available in Europe for the treatment of
moderate to severe chronic pain. It has been evaluated at doses of 35, 52.5, and 70 μg/h for …

Patients requiring chronic opioid therapy may not respond to or tolerate the first opioid
prescribed to them, necessitating rotation to another opioid. They may also require dose …

Objectives To compare the efficacy and tolerability of transdermal buprenorphine in elderly
patients and 2 younger populations, all requiring analgesic treatment for moderate-to-severe …

This paper reviews the current clinical data for the role of transdermal buprenorphine (BUP
TDS) in the treatment of diverse acute and chronic pain syndromes. Literature searches …

Introduction Although chronic opioid therapy is usually initiated using short-acting opioids,
many patients with chronic pain are subsequently converted to long-acting and extended …

Pain is a global epidemic, exacerbated by barriers to access of opioid analgesics.
Regulations about opioids attempt to protect public health from the risks of harmful use of …

Introduction The aim of this study was to evaluate the equianalgesic ratio of transdermal
buprenorphine (TD BUP) with oral morphine and TD fentanyl in a sample of consecutive …